A Pilot Study of Oxaloacetate in Subjects With Treated PD

NCT01741701 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: Oxaloacetate (OAA)
DRUG: Placebo

Sponsor

University of Kansas Medical Center

Collaborators

[object Object]